Finance

Beta
Lists
KIDS:NASDAQ
Orthopediatrics Corp
$19.62
+2.51%
(+0.48) 1D
$19.62
0.00% (0.00)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KIDS...
Open
$19.14
High
$19.69
Low
$19.14
Mkt. cap
503.94M
Avg. vol.
129.46K
Volume
7.00
52-wk high
$23.70
52-wk low
$14.42
EPS
-$1.68
Beta
1.03
Shares outstanding
25.68M
No. of employees
602
Open
$19.14
High
$19.69
Low
$19.14
Mkt. cap
503.94M
Avg. vol.
129.46K
Volume
7.00
52-wk high
$23.70
52-wk low
$14.42
EPS
-$1.68
Beta
1.03
Shares outstanding
25.68M
No. of employees
602
News stories
From sources across the web
Profile
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana. Wikipedia
About Orthopediatrics Corp
CEO-
Employees602
Founded2006
HeadquartersWarsaw, Indiana, United States
SectorMedical device
Websiteorthopediatrics.com
Analyst ratings
Based on 8 analysts giving stock ratings to KIDS in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for KIDS in the last 3 months.
Highest
Current $19.62
$34.00 (+73.29%)
Average
$24.63 (+25.54%)
Lowest
$17.00 (-13.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Maintained
$24.00
+22.3%
06/22/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$23.00
+17.2%
06/12/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$25.00
+27.4%
06/02/2026
Ben Haynor
Lake Street
Buy
Reiterated
$34.00
+73.3%
05/01/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
$22.00
+12.1%
05/01/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$22.00
+12.1%
05/01/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$17.00
-13.4%
05/01/2026
Ravi Misra
Truist Financial
Hold
Reiterated
$17.00
-13.4%
05/01/2026
Michael Matson
Needham
Buy
Reiterated
$30.00
+52.9%
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
61.08M
61.25M
61.60M
59.36M
Cost of goods sold
17.06M
15.98M
16.50M
15.97M
Cost of revenue
17.06M
15.98M
16.50M
15.97M
Research and development expenses
2.16M
2.33M
2.26M
2.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.55M
47.81M
48.35M
49.49M
Operating expense
51.70M
50.14M
50.61M
51.72M
Total operating expenses
68.77M
66.12M
67.11M
67.70M
Operating income
-7.69M
-4.87M
-5.51M
-8.34M
Other non operating income
4.71M
-648.00K
341.00K
-421.00K
EBT including unusual items
-7.06M
-11.90M
-9.76M
-10.86M
EBT excluding unusual items
-4.09M
-7.34M
-7.10M
-10.86M
Income tax expense
49.00K
-125.00K
340.00K
-171.00K
Effective tax rate
-0.69%
1.05%
-3.48%
1.57%
Other operating expenses
-
-
-
-
Net income
-7.11M
-11.77M
-10.10M
-10.69M
Net profit margin
-11.64%
-19.22%
-16.40%
-18.00%
Earnings per share
-0.11
-0.24
-0.26
-0.42
Interest and investment income
-
-
-
-
Interest expense
-1.12M
-1.82M
-1.93M
-2.10M
Net interest expenses
-1.12M
-1.82M
-1.93M
-2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.52M
433.00K
96.00K
-2.61M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of KIDS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer